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A B S T R A C T
Purpose: Previous research has indicated that children with seizures may prefer high fat foods – a
preference compatible with ketogenic and modiﬁed Atkins dietary therapies. The purpose of this
prospective study was to examine the relationship between fat preference and efﬁcacy of therapeutic
diets in treating intractable seizures among a pediatric population.
Methods: Preference for high fat foods was directly assessed in a sample of 30 children prior to
commencing either the ketogenic or modiﬁed Atkins diet. Seizure control was assessed at 1, 3, 6, and 12
months following diet initiation. Using an intent-to-treat analysis, correlations between fat preference
and diet efﬁcacy were examined at each follow-up and across the follow-up period.
Results: At individual follow-ups, correlations between fat preference and diet efﬁcacy varied in terms of
both strength and signiﬁcance; however, modest, positive correlations with fat preference were
signiﬁcant when examining high levels of efﬁcacy (100% seizure reduction, 90% seizure reduction)
across a 1-year follow-up period.
Conclusion: These ﬁndings provide preliminary evidence that fat preference, when directly assessed,
may be a useful predictor of treatment efﬁcacy for the ketogenic and modiﬁed Atkins diets; however,
further research is necessary.
 2014 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
Contents lists available at ScienceDirect
Seizure
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The ketogenic diet, a high fat and low carbohydrate regimen, is
effective for the treatment of intractable epilepsy.1 Research
suggests that the modiﬁed Atkins diet is similarly effective.2,3
Historically, the ketogenic diet is not always considered highly in
the treatment option hierarchy, in part due to perceptions that
children will ﬁnd the high fat and low carbohydrate foods
unpalatable. However, we found that children with seizures
actually exhibit preferences for foods compatible with the
ketogenic diet.4 In our study, children with seizures exhibited* Corresponding author at: Department of Behavioral Psychology, The Kennedy
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high carbohydrate items in comparison to children without
seizures.4 Children with seizures were observed to frequently
choose items such as mayonnaise, butter, and cream cheese over
high carbohydrate items such as candy and chips, often to the
surprise of their parents.
Clinicians and researchers have proposed that the ketogenic
and modiﬁed Atkins diets be considered earlier in the course of the
treatment of epilepsy, rather than as a ‘‘last resort’’, and have
advocated for research to identify variables that might predict the
best responders to these diets.5 Research into EEG prediction
factors have led to mixed results.6,7 Results from our previous
study led us to question whether the extent of a child’s fat
preferences could also have predictive value.
Dekker et al.8 examined the preferences of 43 children and did
not identify a signiﬁcant correlation between fat preferences and
ketogenic diet efﬁcacy. However, these researchers utilized aserved.
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children’s parents (at times recollecting up to 5 years in the past)
in addition to review of a parent-report food log completed prior to
diet commencement, measuring consumption and not preference
speciﬁcally. Given the noted inaccuracy of parent report of child
food preferences,4,9,10 as well as other methodological limitations
of a retrospective study, Dekker et al. stated that further research
should be prospective and should utilize methods that more
closely correlate with a forced-choice paradigm.
To further explore fat preference as a potential predictor of
efﬁcacy of dietary therapy, a systematic forced-choice food
preference assessment procedure was conducted with children
with seizures who were about to start the ketogenic or modiﬁed
Atkins diets and their subsequent response to the diets was
assessed for the year following initiation. Although the preference
assessment included both fat and carbohydrates, only fat prefer-
ence was of interest, as dietary treatment involves increased
consumption of such foods. It was hypothesized that strong
preferences for high fat foods would be positively correlated with
diet efﬁcacy.
2. Materials and methods
2.1. Study population
A group of 33 children and adolescents with a history of
seizures and who were scheduled to begin either the ketogenic or
modiﬁed Atkins diets were recruited from the outpatient Pediatric
Epilepsy clinic at the Johns Hopkins Hospital in Baltimore, MD.
Prior to diet implementation, the study neurologist (EK) described
the assessment procedure to parents and verbal agreement was
obtained. Study research assistants then scheduled an appoint-
ment to obtain informed consent and assent, answer additional
questions, and then implement assessment procedures immedi-
ately before or after the neurology visit. For children starting the
traditional ketogenic diet, the testing was done on the morning of
the admission during a 24-h fasting period (and hence in those
cases, the fast was broken slightly by the small amount of foods).
Starting the diet without a fasting period has been shown to still
maintain long-term diet effectiveness.11 For those starting the
modiﬁed Atkins diet, the testing was done immediately following
the 1-h outpatient clinic visit. These children were then initiated
on the modiﬁed Atkins diet as recommended several days later.
During recruitment, children with signiﬁcant feeding problems
(e.g., gastrostomy tube-fed or formula dependence), severe food
allergies, adherence to special diets (e.g., vegetarian or kosher), or
with prior use of the ketogenic or modiﬁed Atkins diets were
excluded. After recruitment, one female child was disqualiﬁed
from the study due to total noncompliance with study procedures;
two others (one male and one female) did not participate
secondary to family time constraints.
Of the 30 subjects who participated in the study, 15 started the
ketogenic diet and 15 the modiﬁed Atkins diet. From the total
group (15 males and 15 females), 12 were classiﬁed with partial
and 18 with generalized epilepsy. Etiologies included: myoclonic-
astatic epilepsy (Doose syndrome) – 9, childhood absence epilepsy
– 5, temporal lobe epilepsy – 4, idiopathic partial – 3, myoclonic-
absence epilepsy – 2, Sturge–Weber syndrome – 2, Dravet
syndrome – 1, tuberous sclerosis complex – 1, nodular hetero-
topias – 1, encephalitis – 1, and juvenile myoclonic epilepsy – 1.
The mean age for the total group at diet onset was 6.4 years
(SEM = 0.65), and the mean seizure frequency at diet onset was 487
seizures per month (SEM = 16.4). There were no signiﬁcant
differences in seizure frequency at baseline between children in
the ketogenic diet or modiﬁed Atkins diet subgroups.Participants were recruited consecutively from among children
who were being started on the ketogenic or modiﬁed Atkins diet at
Johns Hopkins Hospital. This study was approved by the Kennedy
Krieger Institute and Johns Hopkins Hospital Institutional Review
Boards.
2.2. Food preference assessment procedure
In this prospective study, food preferences were directly
evaluated via a paired choice assessment procedure as described
by Fisher et al.,12with behavioral deﬁnitions as originally described
by Pace et al.13 This applied behavior analysis method was reﬁned
for use with populations of varying degrees of cognitive disability,
and has demonstrated good validity and reliability.12,14
The same standard group of 14 food items from the original
study4 was utilized. These items had been reviewed by a licensed
dietician and chosen on the basis of their nutritional composition
(i.e., high fat/low carbohydrate content versus high carbohydrate/
low fat content).4 For both groups, attempts were made to
represent both higher and lower intensity (e.g., bland) ﬂavors, and
to avoid brand-name and heavily advertised foods.4 The seven high
fat/low carbohydrate items consisted of butter, mayonnaise,
American cheese, cream cheese, bacon, hot dogs, and bologna;
the seven high carbohydrate/low fat items consisted of tortilla
chip, candy corn, jelly bean, pretzel, potato, white bread, and
noodles. They were presented in ‘‘sample-size’’ quantities (e.g., less
than approximately one teaspoon or one bite) in 30 ml clear plastic
cups. Foods that were required to be prepared according to the
manufacturer’s directions were served at the appropriate
temperature.
Identical to our previous study,4 the food preference assess-
ment consisted of a single 15- to 30-min session of repeated
presentations, such that every food item was randomly paired with
every other food item. Items were presented simultaneously, and
the child was asked to choose (either by tasting, fully consuming,
pointing, or verbally stating) one item from each pair. Choices were
noted on pen and paper datasheets. The percentage of trials in
which the child exhibited a positive choice response for each item
was calculated by dividing the number of trials in which the item
was chosen by the number of trials in which it was presented. As in
the prior study,4 an aggregate score for each food group (fat or
carbohydrate) for each child was then obtained by summing those
percentages for all items in each category (fat or carbohydrate).
The highest possible score for a food group was 539 (i.e., if each of
the 7 items in one food group was chosen for all paired trials in
which it was presented).
2.3. Assessment of treatment efﬁcacy
Efﬁcacy of dietary therapy was determined via parental report
of seizure frequency. Neurologists obtained reports, either during
clinic visits or via phone communication, immediately prior to
treatment (baseline) and at 1, 3, 6, and 12 months following
initiation. Diet duration and additional medication changes were
also documented. Diet efﬁcacy was evaluated in terms of reduction
from baseline seizure frequency and was categorized as seizure
free (100%), 90–99%, 50–89%, or <50% reduction.
2.4. Scoring and data analyses
All analyses were done with ‘SPSS for Windows’, version 20.0.
Diet efﬁcacy raw scores were divided into the following categories:
1 = seizure free, 2 = 90–99% reduction, 3 = 50–89% reduction, and
4 = <50% reduction in seizures. We used intent-to-treat analysis.
If a child stopped the diet, we entered their current outcomes
(and used 0% improvement if they were lost to follow-up).
Fig. 1. Fat preference data (medians and interquartile ranges) for each time point
grouped by efﬁcacy.
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efﬁcacy, initial preference scores were correlated with diet efﬁcacy
at each time point (1, 3, 6, and 12 months). Additionally, overall
efﬁcacy was calculated for each participant according to the
percentage of follow-ups at which they exhibited a speciﬁed level
of seizure reduction. Correlations were conducted between initial
fat preference scores and the percentage of follow-ups with 100%
(seizure free), 90%, and 50% reduction.
As these data were nonparametric, Spearman’s rho was used for
all analyses. One-tailed Spearman rank-order correlations for fat
preference scores and seizure control (diet efﬁcacy) were
conducted across the four time points of the observation and at
the levels of efﬁcacy previously speciﬁed. A p value of <.05 was
considered signiﬁcant for all analyses.
3. Results
3.1. Food preferences
As a group, children with seizures had an average aggregate fat
preference score of 329.83 (SD = 92.27). This is very similar to
previous study results in which children with epilepsy had an
average score of 316.79 (SD = 82.55) compared to 265.03
(SD = 77.16) for those without seizures.4
3.2. Diet efﬁcacy and duration
The number of children remaining on the diet and exhibiting
seizure control at each level is displayed in Table 1. At 1 month of
dietary therapy, 23 of 30 participants had >50% seizure reduction,
of which 8 were seizure free. At 3 months, 25 had >50% reduction,
of which 9 were seizure free. At 6 and 12 months, 24 and 20
participants had >50% reduction, respectively, of which 10 at each
time point were seizure free. There were not differences in efﬁcacy
between dietary therapies.
The majority of the patients had their diets adjusted after
initiation (either increased fat or reduced carbohydrates typically)
in order to try and improve efﬁcacy.15 Several patients became
seizure free after having a less robust seizure reduction in the ﬁrst
1–3 months. All children maintained at least moderate urinary
ketosis on either diet. Intent-to-treat was used at each time point.
At the 1-month time point, all 30 participants were still on the
diet. At 3 months, 28 were still on the diet. At 6 and 12 months, 25
and 19, respectively, were still on the diet. Mean diet duration
during the one-year follow-up was 9.6 months. Only one patient
discontinued the diet due to intolerance (at 3 months); her fat
preference score was 416, indicating a high fat preference. Diet
duration was not correlated with fat preference (p = .424).
3.3. Relationship between preferences and treatment efﬁcacy
Fig. 1 depicts the central tendencies (median, IQR) of fat
preference scores for participants exhibiting each level of seizure
reduction at each time point. At 1 month, median fat preference
scores were equivalent across levels of seizure reduction; however,
across the subsequent time points, median fat preference scoresTable 1
Efﬁcacy and duration of ketogenic and modiﬁed Atkins diets.
Seizure reduction 1 Month 3 Months 6 Months 12 Months
1 100% 8 (27%) 9 (30%) 10 (33%) 10 (33%)
2 90–99% 8 (27%) 9 (30%) 7 (23%) 3 (10%)
3 50–89% 7 (23%) 7 (23%) 7 (23%) 7 (23%)
4 <50% 7 (23%) 5 (17%) 6 (20%) 10 (33%)
Continued diet 30 (100%) 28 (93%) 25 (83%) 19 (63%)became more stratiﬁed and were consistently highest among
participants exhibiting 100% seizure reduction.
Statistical analyses of the relationship between fat preference
and efﬁcacy at each time point revealed mixed ﬁndings. The
correlation was statistically non-signiﬁcant at 1 month
(rs[28] = .067, p = .362), signiﬁcant at 3 months (rs[28] = .353,
p = .028), and approached signiﬁcance at 6 and 12 months
(rs[28] = .288, p = .062 and rs[28] = .298, p = .055, respectively).
Although results at individual time points were variable, more
consistent effects were obtained when examining efﬁcacy across
the entire 12-month follow-up period. Fig. 2 depicts scatter plots of
the percentage of participants’ follow-ups at each criterion (100%,
90%, and 50% reduction) as a function of their fat preference
score. The correlation between the percentage of seizure-free
follow-ups and fat preference score was signiﬁcant (rs[28] = .308,
p = .048), as was the correlation with follow-ups with 90%
reduction (rs[28] = .368, p = .023). Fat preference was not signiﬁ-
cantly correlated with percentage of checks with 50% reduction
(rs[28] = .170, p = .183).
3.4. Highest fat scores and efﬁcacy
For the 10 participants with the highest fat preference scores
(scores of 386 or above), 7 (70%) had 90% seizure reduction for 3
of the 4 follow-ups. Their individual data across time points are
represented in Fig. 3; data for the 10 participants with the lowest
fat preference scores are also provided.
4. Discussion
The purpose of this study was to examine whether preferences
for high fat foods compatible with the ketogenic and modiﬁed
Atkins diets were predictive of responsiveness to those diets in
terms of seizure control among pediatric patients. Fat preference
was directly assessed prior to commencing treatment and diet
efﬁcacy was assessed at four time points during a 1-year follow-up
period.
The data from this prospective study provide some evidence to
suggest that fat preference may be predictive of efﬁcacy, but the
results are far from conclusive. Modest correlations between fat
preference and efﬁcacy were observed at the 3, 6, and 12 months
checks, but only the correlation at 3 months was signiﬁcant, with
correlations approaching signiﬁcance at 6 and 12 months. It seems
possible that power was reduced by the small size and
heterogeneity of the sample, such that larger numbers would
have allowed the signiﬁcance noted at 3 months to persist, but that
remains speculation at this point. Additionally, although the data
were not signiﬁcant at the 1-month follow-up, the correlation was
Fig. 2. Percentage of follow-ups with efﬁcacy at 100% reduction (top panel), 90%
reduction (middle panel), and 50% (bottom panel) as a function of each
participant’s fat preference score (x-axis).
Fig. 3. Fat preference score and diet efﬁcacy across time points: individual data for
the third of participants with the highest (‘‘H’’) scores and third with the lowest
(‘‘L’’). Individual fat preference scores are noted next to participant numbers.
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Perhaps the 1-month time period is too early to determine true
ketogenic diet response. Furthermore, it is likely that there are still
undetermined factors that may affect efﬁcacy differentially across
the duration of treatment. For instance, the possibility exists that
fat preferences may change over the course of dietary therapy due
to any number of reasons, ranging from the simple exposure to
novel foods to the modiﬁcation of biologic conditions that
potentially established the original preferences via the diet.
However, due to our design methodology, we did not re-assess
preferences once the diet was started (i.e., could not expose them
to the carbohydrate food items).When exploring overall efﬁcacy, more convincing data were
found. Higher fat preference was moderately and signiﬁcantly
correlated with exhibiting the greatest degree of seizure control,
100% reduction, across the follow-up period. This relationship was
slightly stronger when examining the percentage of follow-ups
with 90% reduction. Interestingly, the correlation between fat
preference and 50% reduction was weak and not signiﬁcant.
Taken together, these results suggest that the relationship between
fat preference and efﬁcacy may not be linear. That is, high fat
preference may be predictive of high efﬁcacy, but low fat
preference may not be predictive of low efﬁcacy (<50% reduction).
As such, a cutoff may exist at which fat preference is most
predictive of high efﬁcacy. Determining if and where such a line
should be drawn would be of particular clinical value. The
individual data from this study suggest that a fat preference score
near 400 may serve as this cutoff; however, future studies with
larger sample sizes would be necessary to directly address this
question. In addition, future research with larger samples could
examine if there are differences in relative efﬁcacy between the
epileptic syndromes, etiology, or level of intellectual disability.
Although tentative, these results provide initial support for the
predictive value of fat preference for responsiveness to dietary
intervention. The modest correlations between fat preference and
diet efﬁcacy obtained in this study stand in contrast to the null
ﬁndings of Dekker et al.8 It seems likely that the difference in
outcomes is a result of the methods used to assess preference.
Further study utilizing direct measurement of preference is
warranted. If these results are replicated and stronger associations
are found, this would have important implications regarding use of
a preference assessment as a possible screening tool for children
being considered for ketogenic diet therapy, and future efforts
could focus on ways to modify the assessment procedure to be
more feasible to implement in a typical child neurology clinic.
5. Conclusion
This small prospective study found modest, positive correla-
tions between fat preference and efﬁcacy on the ketogenic and
modiﬁed Atkins diets. Direct assessment of fat preference may be a
useful screening tool for dietary therapy. High fat preference was
correlated with 90% seizure reduction, but this relation may be
nonlinear. Further research with larger participant samples is
needed to more thoroughly evaluate this relationship, particularly
with respect to any potential cutoff in fat preference score for
predicting high efﬁcacy
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